02/26 Federman & Sherwood Reminds Investors of IMMINENT LEAD PLAINTIFF DEADLINE in Securities Class Action Lawsuit against Vanda Pharmaceuticals, Inc.
To join this class action, please complete the following Investor Certification. [contact-form-7 id=”1039″ title=”Vanda Pharmaceuticals, Inc. Investor Certification”] Oklahoma City, OK (February 26, 2019) – On February 25, 2019, a securities class action lawsuit was filed in the United States District Court for the Eastern District of New York against Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market […]